RHOEN-KLINIKUM AG (RHK.DE) Stock Fundamental Analysis
FRA:RHK - Deutsche Boerse Ag - DE0007042301 - Common Stock - Currency: EUR
Overall RHK gets a fundamental rating of 6 out of 10. We evaluated RHK against 23 industry peers in the Health Care Providers & Services industry. While RHK has a great health rating, its profitability is only average at the moment. RHK has a correct valuation and a medium growth rate.
1. Profitability
1.1 Basic Checks
In the past year RHK was profitable.
RHK had a positive operating cash flow in the past year.
In the past 5 years RHK has always been profitable.
RHK had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
With a decent Return On Assets value of 2.56%, RHK is doing good in the industry, outperforming 61.54% of the companies in the same industry.
With a Return On Equity value of 3.66%, RHK is not doing good in the industry: 61.54% of the companies in the same industry are doing better.
RHK has a worse Return On Invested Capital (2.62%) than 65.38% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for RHK is below the industry average of 5.35%.
The last Return On Invested Capital (2.62%) for RHK is above the 3 year average (2.03%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.56% | ||
| ROE | 3.66% | ||
| ROIC | 2.62% |
ROA(3y)1.79%
ROA(5y)1.62%
ROE(3y)2.5%
ROE(5y)2.27%
ROIC(3y)2.03%
ROIC(5y)2.14%
1.3 Margins
The Profit Margin of RHK (3.08%) is comparable to the rest of the industry.
RHK's Profit Margin has declined in the last couple of years.
The Operating Margin of RHK (3.07%) is comparable to the rest of the industry.
RHK's Operating Margin has declined in the last couple of years.
With a decent Gross Margin value of 65.75%, RHK is doing good in the industry, outperforming 73.08% of the companies in the same industry.
In the last couple of years the Gross Margin of RHK has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 3.07% | ||
| PM (TTM) | 3.08% | ||
| GM | 65.75% |
OM growth 3Y25.19%
OM growth 5Y-11.94%
PM growth 3Y191.57%
PM growth 5Y-7.82%
GM growth 3Y-1.13%
GM growth 5Y-0.92%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so RHK is destroying value.
The number of shares outstanding for RHK remains at a similar level compared to 1 year ago.
The number of shares outstanding for RHK remains at a similar level compared to 5 years ago.
The debt/assets ratio for RHK has been reduced compared to a year ago.
2.2 Solvency
An Altman-Z score of 3.03 indicates that RHK is not in any danger for bankruptcy at the moment.
RHK's Altman-Z score of 3.03 is amongst the best of the industry. RHK outperforms 96.15% of its industry peers.
The Debt to FCF ratio of RHK is 2.18, which is a good value as it means it would take RHK, 2.18 years of fcf income to pay off all of its debts.
RHK has a better Debt to FCF ratio (2.18) than 92.31% of its industry peers.
A Debt/Equity ratio of 0.11 indicates that RHK is not too dependend on debt financing.
The Debt to Equity ratio of RHK (0.11) is better than 92.31% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.11 | ||
| Debt/FCF | 2.18 | ||
| Altman-Z | 3.03 |
ROIC/WACC0.41
WACC6.33%
2.3 Liquidity
A Current Ratio of 2.34 indicates that RHK has no problem at all paying its short term obligations.
With an excellent Current ratio value of 2.34, RHK belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
A Quick Ratio of 2.25 indicates that RHK has no problem at all paying its short term obligations.
RHK's Quick ratio of 2.25 is amongst the best of the industry. RHK outperforms 100.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.34 | ||
| Quick Ratio | 2.25 |
3. Growth
3.1 Past
RHK shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 36.17%, which is quite impressive.
The Earnings Per Share has been decreasing by -4.60% on average over the past years.
Looking at the last year, RHK shows a small growth in Revenue. The Revenue has grown by 5.33% in the last year.
Measured over the past years, RHK shows a small growth in Revenue. The Revenue has been growing by 3.50% on average per year.
EPS 1Y (TTM)36.17%
EPS 3Y198.7%
EPS 5Y-4.6%
EPS Q2Q%-16.67%
Revenue 1Y (TTM)5.33%
Revenue growth 3Y2.48%
Revenue growth 5Y3.5%
Sales Q2Q%9.63%
3.2 Future
RHK is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 17.50% yearly.
Based on estimates for the next years, RHK will show a small growth in Revenue. The Revenue will grow by 5.54% on average per year.
EPS Next Y40.91%
EPS Next 2Y21.54%
EPS Next 3Y18.92%
EPS Next 5Y17.5%
Revenue Next Year3.97%
Revenue Next 2Y4.21%
Revenue Next 3Y4.53%
Revenue Next 5Y5.54%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 19.25 indicates a rather expensive valuation of RHK.
The rest of the industry has a similar Price/Earnings ratio as RHK.
When comparing the Price/Earnings ratio of RHK to the average of the S&P500 Index (29.35), we can say RHK is valued slightly cheaper.
RHK is valuated rather expensively with a Price/Forward Earnings ratio of 19.65.
RHK's Price/Forward Earnings ratio is a bit more expensive when compared to the industry. RHK is more expensive than 61.54% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of RHK to the average of the S&P500 Index (22.10), we can say RHK is valued inline with the index average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 19.25 | ||
| Fwd PE | 19.65 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of RHK indicates a rather cheap valuation: RHK is cheaper than 100.00% of the companies listed in the same industry.
RHK's Price/Free Cash Flow is on the same level as the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 12.48 | ||
| EV/EBITDA | 1.54 |
4.3 Compensation for Growth
RHK's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as RHK's earnings are expected to grow with 18.92% in the coming years.
PEG (NY)0.47
PEG (5Y)N/A
EPS Next 2Y21.54%
EPS Next 3Y18.92%
5. Dividend
5.1 Amount
RHK has a Yearly Dividend Yield of 1.38%.
RHK's Dividend Yield is comparable with the industry average which is at 2.93.
Compared to an average S&P500 Dividend Yield of 2.33, RHK's dividend is way lower than the S&P500 average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.38% |
5.2 History
The dividend of RHK decreases each year by -15.64%.
Dividend Growth(5Y)-15.64%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
DP0%
EPS Next 2Y21.54%
EPS Next 3Y18.92%
FRA:RHK (3/7/2025, 7:00:00 PM)
12.9
-0.1 (-0.77%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners0.69%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap863.78M
Analysts45.71
Price Target13.77 (6.74%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.38% |
Yearly Dividend0.15
Dividend Growth(5Y)-15.64%
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)6.9%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0.32%
Revenue NY rev (3m)1.48%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 19.25 | ||
| Fwd PE | 19.65 | ||
| P/S | 0.57 | ||
| P/FCF | 12.48 | ||
| P/OCF | 6.07 | ||
| P/B | 0.68 | ||
| P/tB | 0.79 | ||
| EV/EBITDA | 1.54 |
EPS(TTM)0.67
EY5.19%
EPS(NY)0.66
Fwd EY5.09%
FCF(TTM)1.03
FCFY8.01%
OCF(TTM)2.13
OCFY16.47%
SpS22.57
BVpS19
TBVpS16.39
PEG (NY)0.47
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.56% | ||
| ROE | 3.66% | ||
| ROCE | 3.19% | ||
| ROIC | 2.62% | ||
| ROICexc | 4.2% | ||
| ROICexgc | 5.2% | ||
| OM | 3.07% | ||
| PM (TTM) | 3.08% | ||
| GM | 65.75% | ||
| FCFM | 4.58% |
ROA(3y)1.79%
ROA(5y)1.62%
ROE(3y)2.5%
ROE(5y)2.27%
ROIC(3y)2.03%
ROIC(5y)2.14%
ROICexc(3y)2.6%
ROICexc(5y)2.68%
ROICexgc(3y)3.11%
ROICexgc(5y)3.2%
ROCE(3y)2.47%
ROCE(5y)2.6%
ROICexcg growth 3Y27.2%
ROICexcg growth 5Y-10.8%
ROICexc growth 3Y27.6%
ROICexc growth 5Y-10.47%
OM growth 3Y25.19%
OM growth 5Y-11.94%
PM growth 3Y191.57%
PM growth 5Y-7.82%
GM growth 3Y-1.13%
GM growth 5Y-0.92%
F-Score6
Asset Turnover0.83
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.11 | ||
| Debt/FCF | 2.18 | ||
| Debt/EBITDA | 1.33 | ||
| Cap/Depr | 115.67% | ||
| Cap/Sales | 4.84% | ||
| Interest Coverage | 14.48 | ||
| Cash Conversion | 129.89% | ||
| Profit Quality | 148.71% | ||
| Current Ratio | 2.34 | ||
| Quick Ratio | 2.25 | ||
| Altman-Z | 3.03 |
F-Score6
WACC6.33%
ROIC/WACC0.41
Cap/Depr(3y)96.73%
Cap/Depr(5y)119.46%
Cap/Sales(3y)4.62%
Cap/Sales(5y)5.96%
Profit Quality(3y)65.77%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)36.17%
EPS 3Y198.7%
EPS 5Y-4.6%
EPS Q2Q%-16.67%
EPS Next Y40.91%
EPS Next 2Y21.54%
EPS Next 3Y18.92%
EPS Next 5Y17.5%
Revenue 1Y (TTM)5.33%
Revenue growth 3Y2.48%
Revenue growth 5Y3.5%
Sales Q2Q%9.63%
Revenue Next Year3.97%
Revenue Next 2Y4.21%
Revenue Next 3Y4.53%
Revenue Next 5Y5.54%
EBIT growth 1Y49.16%
EBIT growth 3Y28.3%
EBIT growth 5Y-8.87%
EBIT Next Year232.54%
EBIT Next 3Y53.53%
EBIT Next 5Y36.1%
FCF growth 1Y482.32%
FCF growth 3Y41.52%
FCF growth 5YN/A
OCF growth 1Y194.01%
OCF growth 3Y-1.28%
OCF growth 5Y17.1%